L-arginine Eye Drops May Help Prevent Cataracts
Author Information
Author(s): Fan Xingjun, Xiaoqin Liu, Potts Breshey, Strauch Christopher M., Nemet Ina, Monnier Vincent M.
Primary Institution: Case Western Reserve University
Hypothesis
Can topical application of L-arginine block advanced glycation in the lens of hSVCT2 transgenic mice?
Conclusion
Topical application of L-arginine significantly reduces advanced glycation end products in the lens, suggesting its potential as a treatment for cataracts.
Supporting Evidence
- L-arginine decreased fluorescence by 40% (p<0.001).
- L-arginine reduced CML, CEL, and glucosepane levels by 35%, 30%, and 37% respectively (p<0.05).
- N-acetylcysteine also showed some effect but was less effective than L-arginine.
Takeaway
Using L-arginine eye drops can help keep the lens of the eye clear and may prevent cataracts.
Methodology
hSVCT2 transgenic mice were treated with L-arginine eye drops for seven months, and lens crystallins were analyzed for advanced glycation end products.
Limitations
The study was conducted on mice, and results may not directly translate to humans.
Participant Demographics
hSVCT2 transgenic mice, 2 months old.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website